InsidersTradesSigma
Sprint Bioscience AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Sprint Bioscience AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Sprint Bioscience AB has published 2 reports. Market capitalisation: €361.9m. The latest transaction was reported on 11 December 2025 (Purchase). Among the most active insiders: Björn Sjöstrand. All data is openly available.
2
Insider Decl.
0
Thresholds
€24,019
2 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Fundamental score
Ranked 16 of 25,973 companies
95.8
score / 100
Value94
Quality98
FCF yld19%
Earn yld21%
EV/EBITDA4.6x
ROE154%
Gross mgn92%
Net mgn55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 December 2025
Declarations2 total
30,000 shares@ €0.13320.0011% mcap16.6% of flowAktieFI:A003U606-1
Ideal exit: 6 Sept 2026 (T+270)
333,520 shares@ €0.060.0055% mcap83.4% of flowBTA (betald tecknad aktie)FI:A003N847-2
Ideal exit: 24 Jan 2026 (T+270)
2 of 2 declarations